Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study

QR Code

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study

ABSTRACT Introduction Standard treatments provide limited benefits for patients with intermediate‐ or advanced‐stage hepatocellular carcinoma (HCC). This retrospective observational study aimed to assess the potential improvements in outcomes associated with systemic therapies in patients receiving...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chengxiang Guo, Weiran Du, Yiwen Chen, Wenbo Xiao, Ke Sun, Yan Shen, Min Zhang, Jian Wu, Shunliang Gao, Jun Yu, Risheng Que, Xing Xue, Xueli Bai, Tingbo Liang
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Series:	Cancer Medicine
Subjects:	combination therapy hepatocellular carcinoma survival transarterial chemoembolization
Online Access:	https://doi.org/10.1002/cam4.70633
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01)

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)
by: Hang Yuan, et al.
Published: (2025-07-01)

Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis
by: Yongfa Lei, et al.
Published: (2025-07-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01)

Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta‐Analysis
by: Wenjie Li, et al.
Published: (2025-07-01)

Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
by: S. A. Ivanov, et al.
Published: (2023-03-01)

Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-12-01)

Comparative Evaluation of Intraarterial Therapy Methods for Hepatocellular Cancer
by: A. P. Petrosyan, et al.
Published: (2025-06-01)

The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis
by: Irsan Hasan, et al.
Published: (2020-12-01)

The Association between Peripheral Th17, Th1, IL-17, and IFN-γ Levels and TACE Response in Patients with Unresectable Hepatocellular Carcinoma with or without Cirrhosis
by: Irsan Hasan, et al.
Published: (2020-12-01)

Adjuvant Hepatic Arterial Infusion Chemotherapy Versus Transarterial Chemoembolization for Preventing Early Recurrence After Surgical Resection in Hepatocellular Carcinoma
by: Xia Y, et al.
Published: (2025-07-01)

Efficacy Analysis of TACE Combined with Lenvatinib and PD-1 Inhibitors in the Treatment of Hepatitis B Virus-Related Unresectable Hepatocellular Carcinoma
by: Yu J, et al.
Published: (2025-07-01)

Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study
by: Liu J, et al.
Published: (2025-07-01)

CASE OF TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA OF THE LIVER THROUGH THE HEPATIC ARTERY CHEMOEMBOLIZATION M
by: A. I. Gritsaenko, et al.
Published: (2017-01-01)

Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer
by: Yuefeng Hu, et al.
Published: (2025-12-01)

Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
by: Lu J, et al.
Published: (2025-05-01)

Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular carcinoma
by: Qingqing Pang, et al.
Published: (2025-07-01)

Pressure Gradient-Driven Embolization b-TACE for HCC: Technical and Diagnostic Step-by-Step Procedural Guide and Literature Review
by: Bianca Rocco, et al.
Published: (2025-07-01)

TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study
by: Lu C, et al.
Published: (2025-07-01)

Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma
by: Abimbola O. Williams, et al.
Published: (2025-05-01)

DCP as a biomarker for TACE efficacy in hepatocellular carcinoma
by: Hui Xie, et al.
Published: (2025-07-01)

Development and Validation of a Radiomics Nomogram Based on Magnetic Resonance Imaging and Clinicoradiological Factors to Predict HCC TACE Refractoriness
by: Dong Y, et al.
Published: (2025-07-01)

A CT-Based Deep Learning Radiomics Scoring System for Predicting the Prognosis to Repeat TACE in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study
by: Dai Y, et al.
Published: (2025-07-01)

Optimal sequencing of locoregional and systemic therapies for intermediate and advanced hepatocellular carcinoma: a network meta-analysis
by: Wei Lu, et al.
Published: (2025-06-01)

Combination of drug-eluting bead transarterial chemoembolization and PD-1 inhibitor for treatment of unresectable head and neck squamous cell carcinoma: an initial, short-term clinical experience in a single-center retrospective cohort study
by: Bo Sun, et al.
Published: (2025-07-01)

Transarterial chemoembolization and early arterial complications after liver transplantation for hepatocellular carcinoma
by: V. V. Borovik, et al.
Published: (2022-09-01)

RESULTS OF TRANSARTERIAL CHEMOEMBOLIZATION OF STOMACH CANCER METASTASES IN THE LIVER
by: D. T. Arybzhanov
Published: (2017-02-01)

Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation
by: Sofia Lopiano, et al.
Published: (2025-05-01)

Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Zelong Liu, et al.
Published: (2025-09-01)

Retrospective Comparative Study to Assess the Safety and Efficacy of Transradial Arterial Access for Hepatic Tumor Embolizations: A Single Operator Experience
by: Ramanivas Sundareyan, et al.
Published: (2023-01-01)

FEATURES ARTERIAL ANATOMY OF THE LIVER AND ENDOVASCULAR CHEMOEMBOLIZATION OF THE HEPATIC ARTERY IN THE TREATMENT OF PRIMARY AND METASTATIC LIVER CANCERS
by: V. V. Plechev, et al.
Published: (2017-02-01)

CHEMOEMBOLIZATION FOR UNRESECTABLE COLORECTAL LIVER METASTASES WITH DRUG-ELUTING MICROSPHERES
by: A. V. Skupchenko, et al.
Published: (2016-02-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Ischemic Stroke Post-Transradial Chemoembolization
by: Almamoon I. Justaniah, et al.
Published: (2024-01-01)

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
by: Yuki Koga, et al.
Published: (2018-08-01)

Transcatheter hepatic arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma before liver transplantation: the prognostic value of alpha-fetoprotein concentrations
by: D. A. Granov, et al.
Published: (2021-01-01)

Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC
by: Bowen Liu, et al.
Published: (2025-07-01)

Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review
by: R. E. Kalinin, et al.
Published: (2024-11-01)

Transarterial chemoembolization in the treatment of primary and recurrent pelvic tumors with peritoneal involvement: what results can be expected?
by: E. A. Zvezdkina, et al.
Published: (2022-09-01)

Enhancing Transradial Transarterial Microembolization Efficiency and Patient Satisfaction with Oral Benzodiazepine Premedication
by: Hsuan-Yin Lin, et al.
Published: (2025-06-01)